Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease

NIH RePORTER · NIH · R35 · $1,200,000 · view on reporter.nih.gov ↗

Abstract

Summary I believe that combining disease gene discovery approaches with in-depth follow-up mechanistic and functional studies is a unique aspect of my research program. Our recent discovery of “human-specific” pathways and phenotypes (compared to mice) in midbrain DA neurons has led us to focus on patient-derived DA neurons to examine the function of PD-linked genes. By employing co-cultures of iPS-derived neurons, microglia and astrocytes, we will examine the interplay of cell-autonomous and no-cell autonomous pathways that lead to dysfunction of midbrain DA neurons in PD. Moreover, we will use innovative technology to simultaneously examine a large number of genetic variants in a pooled iPS approach that has not been possible previously. Finally, our recent discovery of direct contacts between lysosomes and mitochondrial has opened a completely new opportunity to examine inter- and intra-organellar dynamics in neurodegeneration. The R35 award would provide me the time, freedom and stability to be even more adventurous and, as always, follow the most interesting biology to have a high impact on the field.

Key facts

NIH application ID
10396113
Project number
5R35NS122257-02
Recipient
NORTHWESTERN UNIVERSITY
Principal Investigator
DIMITRI KRAINC
Activity code
R35
Funding institute
NIH
Fiscal year
2022
Award amount
$1,200,000
Award type
5
Project period
2021-05-01 → 2029-04-30